
2,6-Diamino-3,5-dithiocyanopyridine | CAS:2645-32-1
2,6-Diamino-3,5-dithiocyanopyridine
- 名称:2,6-二氨基-3,5-二硫氰基吡啶 | 2,6-Diamino-3,5-dithiocyanopyridine
- CAS号:2645-32-1
- 别名:PR 619
- 分子式:C7H5N5S2
- 分子量:223.28
- EINESC号:
产品描述
物理化学性质
熔点 | 210 ºC** |
---|---|
密度 | 1.61±0.1 g/cm3 (20 ºC |
安全数据
没有数据 | 没有数据 |
---|
SDS
来源 | SDS样本 |
---|---|
没有数据 | 没有数据 |
产品合成路线
名称 | CAS号 |
---|
更多
文章
同行评议文献
Protein Kinase A Deregulation in the Medial Prefrontal Cortex Impairs Working Memory in Murine Oligophrenin-1 Deficiency.Chun-Lei Zhang et al.The Journal of neuroscience : the official journal of the Society for Neuroscience, 37(46), 11114-11126 (2017-10-17)
Upregulation of Epac-1 in Hepatic Stellate Cells by Prostaglandin EMarlies Schippers et al.The Journal of pharmacology and experimental therapeutics, 363(2), 126-135 (2017-09-03)
Parathyroid Hormone-Like Hormone Induces Epithelial-to-Mesenchymal Transition of Intestinal Epithelial Cells by Activating the Runt-Related Transcription Factor 2.Shuying He et al.The American journal of pathology, 188(6), 1374-1388 (2018-03-27)
One-day treatment of small molecule 8-bromo-cyclic AMP analogue induces cell-based VEGF production for in vitro angiogenesis and osteoblastic differentiation.Kevin W-H Lo et al.Journal of tissue engineering and regenerative medicine, 10(10), 867-875 (2014-02-05)
Epac activation sensitizes rat sensory neurons through activation of Ras.Behzad Shariati et al.Molecular and cellular neurosciences, 70, 54-67 (2015-11-26)
cAMP attenuates angiotensin-II-induced Egr-1 expression via PKA-dependent signaling pathway in vascular smooth muscle cells.Estelle R Simo-Cheyou et al.Canadian journal of physiology and pharmacology, 95(8), 928-937 (2017-05-02)
Epac is required for GLP-1R-mediated inhibition of oxidative stress and apoptosis in cardiomyocytes.Supachoke Mangmool et al.Molecular endocrinology (Baltimore, Md.), 29(4), 583-596 (2015-02-27)
备注
Products protected by valid patents are not offered for sale in countries where the sale of such products constitutes a patent infringement and its liability is at buyer's risk.
Products currently covered by valid US Patents are offered for R&D use in accordance with 35 USC 271 +A13(1).
名称 | CAS号 |
---|

相关产品
相关资讯
问
热门标签
询 单
请 填 写 相 关 信 息
- 请填写产品名称!
- CAS号
- 请正确填写公司名称!
- 请正确填写联系人!
- 请正确填写联系电话!
- 请正确填写联系邮箱!
- 请描述您的问题!